NCT01840150View on ClinicalTrials.gov

Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 23, 2012

Primary Completion Date

March 22, 2018

Study Completion Date

July 5, 2019

Conditions
Stage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung Cancer
Interventions
PROCEDURE

breath test

Undergo NA-NOSE breath test

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

19111-2497

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT01840150 - Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer | Biotech Hunter | Biotech Hunter